States set to crack down on compounding

Wednesday, April 30, 2003

YARMOUTH, Maine — Look for more state pharmacy boards to seriously consider some kind of certification for companies that want to compound drugs, including respiratory inhalations like albuterol and ipratropium.

One of the biggest concerns that pharmacy boards have is that many pharmacies that compound respiratory medications have never had any formal training in respiratory compounding, said Mickey Letson, president of wholesale drug distributor Letco Medical.

“I’ve been telling people for years that they need to go through some kind of certification and inspection of your pharmacy by a qualified individual,” Letson said. “Most of these guys say give me a formula and let me go. That is not going to cut it much longer.”

Letco runs a compounding training program accredited by the American College of Pharmaceutical Education (ACPE).

Avery Pharmaceuticals has also begun offering ACPE accredited continuing education courses on all compounding practices. HME

“It is our obligation to reinforce good compounding process because the more good pharmacies out there following good compounding process, the longer the market will be available,” said Avery’s Nick Letson. “If the pharmacies aren’t allowed to compound or aren’t profitable at unit dose medications, than the respiratory wholesaler is out of business.” HME